HLA不相合异基因造血干细胞移植后输注供者CD34^+祖细胞来源的自然杀伤细胞可预防肿瘤复发
被引量：1
Generation of donor natural killer cells from CD34^+ progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation:a feasibility study
出处
《中华移植杂志（电子版）》
CAS
2010年第3期16-16,共1页
Chinese Journal of Transplantation(Electronic Edition)
同被引文献4
1 Fengzhen Mo,Siliang Duan,Xiaobing Jiang,Xiaomei Yang,Xiaoqiong Hou,Wei Shi,Cueva Jumbo Juan Carlos,Aiqun Liu,Shihua Yin,Wu Wang,Hua Yao,Zihang Yu,Zhuoran Tang,Shenxia Xie,Ziqiang Ding,Xinyue Zhao,Bruce D.Hammock,Xiaoling Lu.Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy[J] .Signal Transduction and Targeted Therapy,2021,6(3):1021-1032. 被引量：6
2 Yuan-Hong Xie,Ying-Xuan Chen,Jing-Yuan Fang.Comprehensive review of targeted therapy for colorectal cancer[J] .Signal Transduction and Targeted Therapy,2020,5(1):2155-2184. 被引量：48
3 Yun Wang,Min Wang,Hao-Xiang Wu,Rui-Hua Xu.Advancing to the era of cancer immunotherapy[J] .Cancer Communications,2021,41(9):803-829. 被引量：14
4 Jina Bae,Yoonyee Song.Engineering a cell-penetrating hyperstable antibody scFv(Ras)-An extraordinary approach to cancer therapeutics[J] .Synthetic and Systems Biotechnology,2021,6(4):343-350. 被引量：2
二级引证文献5
1 雷晓敏,范冬梅,袁向飞,卢杨,张砚君,王建祥,熊冬生.Anti-CD19Fab-(CP)_(3)新型二聚化抗体的构建及靶向性观察[J] .山东医药,2023,63(28):14-17.
2 Bin Zhang,Chun-Mei Wang,Hao-Xiang Wu,Feng Wang,Yang-Yang Chai,Ye Hu,Bing-Jing Wang,Zhou Yu,Rong-Hua Xia,Rui-Hua Xu,Xue-Tao Cao.MFSD2A potentiates gastric cancer response to anti-PD-1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response[J] .Cancer Communications,2023,43(10):1097-1116. 被引量：3
3 安然,刘明珠,张露,彭上,甄翔程,闵静婷,李正红.人源抗c-Met单链抗体腹腔注射可抑制A549肺腺癌荷瘤小鼠移植瘤生长[J] .细胞与分子免疫学杂志,2024,40(6):549-555.
4 ZHENGYI WANG,LIANG ZHOU,XIAOYING WU.Influencing factors and solution strategies of chimeric antigen receptor T-cell therapy(CAR–T)cell immunotherapy[J] .Oncology Research,2024,32(9):1479-1516.
5 Xueqiang Peng,Jianjun Fang,Chuyuan Lou,Liang Yang,Shaobo Shan,Zixian Wang,Yutong Chen,Hangyu Li,Xuexin Li.Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy[J] .Acta Pharmaceutica Sinica B,2024,14(8):3432-3456.
1 史沛杰,方建培.嵌合抗原受体T细胞(CAR-T)疗法在常见儿童肿瘤治疗领域中的应用[J] .中国小儿血液与肿瘤杂志,2017,22(1):42-45. 被引量：3
2 张启科,周红英,陈淑萍,王勇强,王婷.输注供者淋巴细胞治疗慢性粒细胞白血病1例[J] .白血病．淋巴瘤,2002,11(4):252-253.
3 袁海龙,温丙昭,曲建华,江明,哈力达·亚森,李玲.HLA不相合与相合外周血干细胞移植后发生出血陛膀胱炎的多因素对比分析[J] .白血病．淋巴瘤,2008,17(6):439-441.
4 曹玲,罗依.HLA差异对非清髓HLA半相合骨髓移植联合移植后大剂量环磷酰胺治疗患者预后的影响[J] .中华移植杂志（电子版）,2010,4(4).
5 陈静.儿童难治性急性髓系白血病异基因造血干细胞移植现状[J] .中国小儿血液与肿瘤杂志,2010,15(5):199-202. 被引量：1
6 许戟,朱雨,潘良琴,段丽敏,朱华渊,陆化,陈丽娟,李建勇,钱思轩.DCAG联合HLA不相合的干细胞输注治疗老年初发急性髓系白血病的疗效观察[J] .南京医科大学学报（自然科学版）,2015,35(3):404-406. 被引量：3
7 胡俊斌,郭涛,宋善俊,邹萍,陈涵薇.异基因骨髓移植后早期输注供者白细胞治疗复发性急性白血病一例[J] .中华血液学杂志,1999,20(8):435-436.
8 于嗣俭,戴敏,孙竞,范志平,黄芬,张钰,江千里,周红升,徐丹,孟凡义,刘启发.亲缘HLA不相合与无关HLA全相合供者造血干细胞移植治疗血液肿瘤疗效比较[J] .中华血液学杂志,2014,35(9):826-830. 被引量：5
9 朱兴虎,张丽,魏旭东,汪萍,宋永平.非血缘HLA不相合脐血移植治疗儿童重型再生障碍性贫血二例[J] .中华儿科杂志,2006,44(2):143-144. 被引量：1
10 李维佳,温柏平,何争春,李惠民.供者淋巴细胞输注治疗急性白血病异基因骨髓移植后复发2例[J] .白血病．淋巴瘤,2005,14(2):103-104.
